DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 24 Apr · 14:39 IST

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 24, 2026, titled "Intimation of Earnings call".

Board & Shareholder Meetings View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹1325.00
prior close
₹1323.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.5-0.3+0.8+1.7+0.2+0.0-2.8-1.3+0.4+0.6+0.2-13.0
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories has notified the exchanges about the schedule for releasing its Q4 and full year FY26 financial results. The results for the quarter and year ended March 31st, 2026 will be announced on Tuesday, May 12th, 2026 after the Board Meeting. An earnings call hosted by the management will follow on the same day at 19:30 PM IST / 10:00 AM ET. The results, press presentation, and earnings call transcript will be available on the company's website and stock exchanges.

Likely market impact

This is a routine scheduling disclosure. The actual impact on shareholders will depend on the financial results themselves, which will be disclosed on May 12th, 2026.